Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma

Cancer

Volumn 106, Issue 6, 2006, Pages 1227-1236

  Matsuura, Kazuo ^a   Yamaguchi, Yoshiyuki ^a   Ueno, Hideaki ^a   Osaki, Akihiko ^a   Arihiro, Koji ^a   Toge, Tetsuya ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Breast carcinoma; Dendritic cells; Regulatory T cells; Sentinel lymph nodes; T helper type 1; T helper type 2

Indexed keywords

ANTIBODY; B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DYE; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MAMMAGLOBIN; MESSENGER RNA; PHYCOERYTHRIN; RNA; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BREAST CARCINOMA; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE STATUS; LYMPH NODE METASTASIS; LYMPHOCYTE; MICROMETASTASIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; AGED; ANTIGENS, CD; BREAST NEOPLASMS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENTINEL LYMPH NODE BIOPSY; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 33644836887     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21729     Document Type: Article

References (33)

1. Mescher MF. Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes. Immunol Rev. 1995;146:177-210.
2. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 2001;106:263-266.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
4. Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev. 1997;156:25-37.
5. Lechmann M, Berchtold S, Hauber J, et al. CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol. 2002;23:273-275.
6. Zhou LJ, Schwarting R, Smith HM, et al. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol. 1992;149:735-742.
7. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 1995;154:3821-3835.
8. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA. 1996;93:2588-2592.
9. Ma X, Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol. 2001;79:55-92.
10. Rieser C, Ramoner R, Holtl L, et al. Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma. Urol Int. 1999; 63:151-159.
11. Halak BK, Maguire HC, Lattime EC. Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site. Cancer Res. 1999;59:911-917.
12. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
13. Ichihara F, Kono K, Takahashi A, et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res. 2003;9:4404-4408.
14. Gould EA, Winship T, Philbin PH, et al. Observation on a "sentinel node" in cancer of the parotid. Cancer. 1960;13:77-78.
15. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
16. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
17. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-340.
18. Kitagawa Y, Fujii H, Mukai M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am. 2000;80:1799-1809.
19. Gillanders WE, Mikhitarian K, Hebert R, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004; 239:828-840.
20. Iwamoto M, Shinohara H, Miyamoto A, et al. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer. 2003;104:92-97.
21. Mitas M, Mikhitarian K, Walters C, et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 2001;93:162-171.
22. Ueno H, Yoshida K, Hirai T, et al. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real time quantitative reverse transcription polymerase chain reaction. Anticancer Res. 2003;23:1701-1708.
23. Cochran AJ, Morton DL, Stern S, et al. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol. 2001;14:604-608.
24. Essner R, Kojima M. Surgical and molecular approaches to the sentinel lymph nodes. Ann Surg Oncol. 2001;8:31-34.
25. Essner R, Kojima M. Dendritic cell function in sentinel node. Oncology. 2002;16:27-31.
26. Lee JH, Torisu-Itakara H, Cochran AJ, et al. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res. 2005;11:107-112.
27. Huang RR, Wen D-R, Guo J, et al. Selective modulation of paracortical dendritic cells and T-lymphocytes in breast sentinel lymph nodes. Breast. 2000;6:225-232.
28. Schule J, Bergkvist L, Hakansson L, et al. Down-regulation of the CD3 zeta chain in sentinel node biopsies from breast cancer patients. Breast Cancer Res Treat. 2002;74:33-40.
29. Ishigami S, Natsugoe S, Uenosono Y, et al. Infiltration of antitumor immunocytes into the sentinel node in gastric cancer. J Gastrointest Surg. 2003;7:735-739.
30. Poindexter NJ, Sahin A, Hunt KK, et al. Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer. Breast Cancer Res. 2004;6:408-415.
31. Akira F, Masanobu M, Takehiko K, et al. Involvement of IL-4 in human glomerulonephritis: an in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA. J Am Soc Nephrol. 1997;8:730-741.
32. Fujimoto T, Duda RB, Szilvasi A, et al. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J Immunol. 1997;158:5619-5626.
33. Jonuleit H, Schmitt E, Steinbrink K, et al. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001;22:394-400.